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Protein nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that 
regulates expression of numerous proteins. These proteins protect cells against oxidative 
stress and reinstate cellular homeostasis. Oxidative stress activates Nrf2, leading to its 
translocation and accumulation in the nucleus.   
Oxidative stress is defined as an imbalance between the production of reactive oxygen 
species (ROS) and the cellular antioxidant defense capacity, in favor of the ROS. Oxidative 
stress has been associated with ageing and diseases including cancer, diabetes, 
atherosclerosis, inflammation, and neurodegeneration.   
Since Nrf2 is ubiquitously expressed in all tissues, and Nrf2 levels and cellular 
location change during oxidative stress, it is desirable to establish a method to evaluate the 
state of Nrf2 in both cytoplasm and nuclear fractions. Peripheral blood mononuclear cells 
(PBMCs) can be obtained in a non-invasive manner by blood sampling and are therefore a 
preferable model system for monitoring Nrf2 levels and localization in response to oxidative 
stress. At Stavanger University Hospital, biomarkers such as protein carbonyls (PC), 
malondialdehyde (MDA), and advanced oxidation protein products (AOPP) in blood samples 
from patients have been used in different studies to assess oxidative stress induced by 
diseases. Nrf2 determination, if successful, can then become a supplementary test in addition 
to the tests of the aforementioned conventional biomarkers.   
In this research, Western blot and an enzyme-linked immunosorbent assay (ELISA)-
based TransAM Nrf2 kit were utilized for the detection of Nrf2 in PBMCs. Moreover, purity 
of the fractions was also determined with Western blot. The results from the purity 
determination indicated some contamination in the nuclear fractions, suggesting further 
optimization of fractionation protocol used. Despite that limitation, the results showed it was 
possible to use Western blot and the ELISA-based TransAM Nrf2 kit to detect and measure 
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AMP:   adenosine monophosphate 
AOPP:  advanced oxidation protein products 
ARE:  antioxidant response element 
BSA:   bovine serum albumin 
BTB:  broad-complex, tramtrack and bric-à-brac 
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CNC:   cap’n’collar 
CPT:   cell preparation tube 
CREB:  cyclic AMP responsive element binding protein 
CSF:  cerebrospinal fluid 
CTR:  C-terminal region 
Cul3:  cullin 3 
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DC domain:   domain including DGR and CTR 
DTT:   dithiothreitol 
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EDTA: ethylenediaminetetraacetic acid 
ELISA:  enzyme-linked immunosorbent assay  
EpRE:  electrophile response element 
g:   gravitational force 
GAPDH: glyceraldehyde-3-phosphate dehydrogenase 
GC-MS: gas chromatography-mass spectrometry 
GPx:   glutathione peroxidase  
GSH:  glutathione   
GSR:   glutathione reductase  
GSSG:  glutathione disulfide  
GST:  glutathione S-transferase 
HAT:   histone acetyltransferase 




HO-1:  heme oxygenase-1 
HPLC:  high-performance liquid chromatography 
HPRT:  hypoxanthine guanine phosphoribosyl transferase 
HRP:  horseradish peroxidase 
IsoPs:  isoprostanes 
IVR:  the intervening region 
kDa:   kilodalton 
Keap1:  kelch-like ECH-associated protein 1 
LDS:   lithium dodecyl sulfate 
Maf:  musculo-aponeurotic fibrosarcoma 
MDA:  malondialdehyde 
MW:   molecular weight 
NADPH:  nicotinamide adenine dinucleotide phosphate 
NO2-Tyr:  nitrotyrosine 
NP-40:  non-ionic polyoxyethylene   
NQO1: quinone oxidoreductase 
Nrf2:   nuclear factor erythroid 2-related factor 2 or nuclear factor (erythroid-derived 
2)-like 2 
Neh:  Nrf2-ECH homology 
NTR:  N-terminal region 
OD:  optical density 
p300:   transcriptional coactivator with HAT activity 
PBMC:  peripheral blood mononuclear cell 
PBS:   phosphate-buffered saline   
PC:   protein carbonyls 
PMNLs: polymorphonuclear leucocytes 
pSS:  Sjögren’s syndrome  
PVDF:  polyvinylidene difluoride  
REAP:  rapid, efficient and practical 
RING:  really interesting new gene   
RIPA:   radioimmunoprecipitation assay  
ROC1:  RING of cullins-1 
ROS:   reactive oxygen species 




SDS:   sodium dodecyl sulfate  
SDS-PAGE:  sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SFN:  sulforaphane  
SOD:   superoxide dismutase  
tBHQ:  tert-butylhydroquinone 
TBS:   tris-buffered saline 
TBST:  tris-buffer saline with 0.1% Tween® 20  
Ub:  ubiquitin 
UV:   ultraviolet 
w/v:  weight per volume 








Reactive oxygen species (ROS) are continually produced in the body as a result of 
aerobe metabolism [1]. These molecules are vital for life because they contribute to immune 
response and are a part of cell signaling pathways [2-4]. In normal cells, ROS level is strictly 
controlled and balanced by antioxidant defense machinery since a high concentration of ROS 
is toxic and can potentially damage and modify the cellular components such as lipids, 
nucleic acid bases, and proteins [5]. However, the balance between the level of ROS and the 
ability of the body’s defense system can be perturbed, which leads to oxidative stress [1, 6]. 
Oxidative stress is involved in the pathogenesis of many serious diseases [7, 8]. For this 
reason, the assessment of the oxidative stress level is desired in clinical examination. The 
most commonly used approaches are measurements of biomarkers, metabolites, and target 
products of ROS in cerebrospinal fluid (CSF), tissues, blood, and urine. Some biomarkers of 
oxidative stress are isoprostanes (IsoPs), malondialdehyde (MDA), 4-hydroxnonemal (HNE) 
from the oxidation of lipids, advanced oxidation protein products (AOPP), nitrotyrosine 
(NO2-Tyr), and protein carbonyls (PC) from the protein oxidation [2, 7, 9, 10]. Examples of 
methods used in detection are high-performance liquid chromatography (HPLC), gas 
chromatography-mass spectrometry (GC-MS), spectrophotometry, and enzyme-linked 
immunosorbent assay (ELISA) [7, 10]. Another approach to detect oxidative stress is to 
measure concentration of the antioxidants glutathione (GSH), catalase (CAT), and superoxide 
dismutase (SOD). Some efforts to directly detect ROS have also been made using electron 
spin resonance with spin traps [11]. However, the equipment cost, instability of ROS, lack of 
specificity and selectivity make the methods less attractive and more challenging in clinical 
analysis where most test materials are tissues and body fluids [7, 11, 12].   
At Stavanger University Hospital, oxidative stress has been studied in some clinical 
projects. So far, the biomarkers PC, MDA, and AOPP have been used. In one study, both 
AOPP and MDA concentration increased in patients with IgA nephropathy compared to 
controls, but their concentrations were also uncovered to be dependent on age and sex [13]. 
In another study, patients with primary Sjögren’s syndrome (pSS) had elevated PC and AOPP 
level compared to healthy subjects. Nevertheless, no association between the PC or AOPP 
level and fatigue was found in this study. The outcome was unexpected, as oxidative stress is 
hypothesized to be a fatigue-induced phenomenon. Fatigue, defined as an overwhelming 




disablement. Fatigue is also common in patients with chronic inflammatory diseases, and pSS 
patients were reported to have experienced fatigue [2, 14]. The findings from the studies have 
raised questions as to whether measurement of PC, MDA, and AOPP alone was sufficient to 
give a complete picture of oxidative stress status in the body. 
In 1994, Moi and colleagues successfully cloned and characterized a gene encoding a 
protein which was named nuclear factor erythroid 2-related factor 2 (Nrf2) [15]. Nrf2 is today 
regarded as one of the most important transcription factors in the cellular protection against 
endogenous and exogenous oxidative stress. Under oxidative stress, activated Nrf2 
translocates to the nucleus and heterodimerizes with musculo-aponeurotic fibrosarcoma 
(Maf). The Nrf2-Maf dimer binds to antioxidant response element (ARE) found in Nrf2 
target genes and initiates their expression. The genes expressed encode different enzymes and 
proteins which protect cells against oxidative damage [16]. Since Nrf2 is ubiquitously 
expressed in all tissues [17], and there is a clear association between oxidative stress and the 
increased level of Nrf2 in the nucleus, Nrf2 might be a useful supplementary test which can 
be used besides PC, MDA, and AOPP. By relatively quantifying cytoplasmic and nuclear 
levels of Nrf2, the Nrf2-regulated antioxidant defense induced by oxidative stress could be 
better studied and offer a new approach to assess the oxidative stress status in patients.   
The most used method in the investigation of Nrf2 is conventional Western blot. 
Another used method is ELISA.  
The purpose of this project was to compare Western blot and ELISA-based TransAM 
Nrf2 kit for detection and measurement of Nrf2 levels in PBMCs. Cell cultures have been 
used in many studies on Nrf2 function, thus in vivo studies or studies on cells from 
individuals are needed. In this study, PBMCs were used as a model system for Nrf2. PBMCs 
were isolated from blood samples, lysed and subjected to Western blot analysis with three 
different anti-Nrf2 antibodies. The antibodies detected different epitopes in Nrf2 protein. 
After the characterization, Western blot was used again to detect Nrf2 in fractions of PBMCs 
to examine whether it had the same characteristic as in the whole cell lysates. Next, the purity 
of the cellular fractions was determined, also with Western blot, using antibodies against 
reference proteins found exclusively in nuclear or cytosolic fractions. Finally, the TransAM 









Figure 1.1. Flow chart of the research process in the project. PBMC: Peripheral blood 
mononuclear cell. Nrf2: Nuclear factor erythroid 2-related factor 2.  
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2.1 ROS and oxidative stress  
 
Human cells have their own aerobic cellular respiration process in which the inspired 
oxygen (O2) is consumed. The physical participation of O2 takes place in the mitochondrial 
electron transport chain which has water (H2O) as one of its final products [18]. However, the 
O2 molecules can also be partially reduced instead of completely reduced to H2O by electrons 
in the mitochondria. If one single electron is transferred to O2, superoxide ion (O2
• -) is 
formed. The acquirement of two electrons gives hydrogen peroxide (H2O2). Both O2
• - and 
H2O2 are called ROS or oxidants. ROS refer to both free radical and nonradical derivatives of 
O2 [1, 19-21] (table 2.1). Free radicals are ROS which contain one or more unpaired electrons 
[5, 17]. Besides mitochondria, ROS are also produced in microsomes, peroxisomes, and 
phagocytes [17, 20, 22, 23].     
 
Table 2.1. Some endogenous reactive oxygen species (ROS) 
Reactive oxygen species (ROS) 
Free radicals Nonradicals 
Hydroxyl (•OH) 
Alkoxyl (RO•) 
Peroxyl radicals (ROO•)  
Superoxide ion (O2
• -)  
Hydrogen peroxide (H2O2) 
Hypochlorous acid (HOCl)  
Peroxynitrite (ONOO-)  
Organic hydroperoxides (ROOH) 
 
 
In normal cells ROS are always generated in low and moderate concentrations in a 
strictly controlled manner as a result of aerobic metabolism [20]. They contribute to many 
physiological and pathophysiological processes in mammalian cells such as cell growth, cell 
proliferation, cell survival, defense against infectious agents, and activation of signaling 
pathways [17, 24-27]. 
When the concentration of ROS becomes so high that the protective mechanisms 
inside the body cannot handle, the cells experience a condition called oxidative stress. Since 




functions [7, 17, 24, 25, 28, 29], oxidative stress is involved in pathogenesis of many 
conditions and diseases such as ageing, cancer, Alzheimer’s disease, Parkinson’s disease, 
Down syndrome, atherosclerosis, diabetes mellitus, ischemia, and rheumatoid arthritis [8, 17, 
19, 25]. 
Oxidative stress can also be caused by xenobiotic factors which are, for example, UV 
light, cigarette smoking, environmental toxins, medicines, alcohol, and radiation [20, 30, 31].  
 
2.2 Nuclear factor erythroid 2-related factor 2  
 
2.2.1 Machinery for cell protection against oxidative stress 
 
Oxidative stress, whether endogenous or exogenous, is an inevitable challenge for all 
animal species since aerobic metabolism is entirely dependent on oxygen. Therefore, cells 
have been equipped with several mechanisms to counteract ROS-induced damages and 
maintain their redox homeostasis. These mechanisms include the use of antioxidants and 
antioxidant enzymes, stimulation of endogenous signaling pathways to protect cells from 
toxic effects of ROS, and reparation of cellular injuries [5, 32].  
CAT, SOD, and glutathione peroxidase (GPx) are some representatives of antioxidant 
enzymes that protect the cells against ROS. Catalase deactivates peroxide, SOD neutralizes 
O2
• -, while GPx catalyzes reactions where peroxides are reduced to alcohols and H2O by 
antioxidant GSH [5, 20, 32].  
 
2.2.2 The involvement of Nrf2 
 
Nrf2 regulates the expression of genes coding for antioxidants and antioxidant 
enzymes in the machinery against oxidative stress [33]. Nrf2 is a member of the cap’n’collar 
(CNC) subfamily of the basic region-leucine zipper (bZIP) transcription factor protein family 
[15, 34-36]. The protein is characterized by typical bZIP motif and a CNC domain. It is 
present not only in vertebrates but also in invertebrates and can be found ubiquitously in all 
tissues with different levels of expression. The gastrointestinal tract, liver, kidney, and lungs 




Nrf2-ECH (erythroid cell-derived protein with CNC homology) homology  (Neh1-Neh6) that 
are well conserved and have different functionalities [38-40] (figure 2.1A).    
Under normal and unstressed conditions, Nrf2 is sequestered and degraded by 
proteasome in the cytoplasm by ubiquitination, which is mediated by kelch-like ECH-
associated protein 1 (Keap1) [39, 41-46] and cullin 3 [47-50].  
Keap1 was first described by Itoh, Wakabayashi et al. (1999) as a Nrf2 negative 
regulator in the cytoplasm [39]. Keap1 is a zinc finger protein [38] belonging to the broad-
complex, tramtrack, and bric-à-brac (BTB)-Kelch protein family [51]. Keap1 comprises the 
N-terminal region (NTR), BTB domain, the intervening region (IVR), the double glycine 
repeat (DGR) or Kelch repeat, and the C-terminal region (CTR) [52-54]. DGR and CTR 
constitute the DC domain in Keap1 [17, 53, 55] (figure 2.1B). The protein resides mainly in 
the cytoplasm as homodimer dimerized through its BTB domain, but a small amount of 







Figure 2.1. The domain structures of Nrf2 (A) and Keap1 (B). 
 
Interaction between Nrf2 and functional Keap1 homodimer [57] takes place at the N-
terminal Neh2 domain and the DC domain in the Nrf2 protein and the Keap1 protein 
respectively [39, 55]. The DC domain binds to the Neh2 domain via either DLG or ETGE, 






Cullin 3 (Cul3) associates with the BTB and IVR region in the Keap1 at the N-
terminal domain [47, 48, 50, 58]. Cul3 binds to the ROC1 (really interesting new gene 
(RING) of Cullin) protein at C-terminal domain [47], resulting in a protein complex called 
ubiquitin ligase. Ubiquitin ligase facilitates the transfer of ubiquitin (Ub) from ubiquitin-
conjugating enzyme to substrate protein [59] (figure 2.2).   
Since Keap1, and not Cul3, binds directly to Nrf2, Keap1 functions as an adaptor 










Figure 2.2. Models depicting structure of ubiquitin ligase (A) and Nrf2 regulation by Keap1 
and Cul3 (B).  Keap1 homodimerizes via its BTB domains. The two DC domains in the 
Keap1 homodimer bind to one Nrf2 molecule. BTB and IVR region in the Keap1 associate 
with the Cul3 in the ubiquitin ligase.  
 
Upon exposure to oxidative stress, Keap1 residues sense the abnormal changes and 
undergo diverse modifications [38, 43, 60]. These modifications result in disruption of the 
Keap1-Nrf2 association, thus preventing Nrf2 ubiquitination and degradation, which liberates 






In the nucleus, Nrf2 forms a heterodimer with small protein Maf [61]. The Nrf2-Maf 
dimer binds to ARE [62], also referred to as electrophile response element (EpRE) [63] in the 
promoter regions of target cytoprotective genes [64]. In addition, the Nrf2-Maf dimer recruits 
other transcription coactivators such as CREB (cyclic AMP responsive element binding 
protein) binding protein (CBP) and p300 [65-67], resulting in a broader transcriptional 
response [68, 69] (figure 2.3).  
Figure 2.3. Under normal and unstressed conditions, Nrf2 is repressed by Keap1 and 
subsequently degraded. If Keap1 senses oxidative stress, Nrf2 is liberated and activated. 
Then, Nrf2 translocates to the nucleus and binds to Maf, CBP, and p300. The complex binds 
to ARE found in Nrf2 target genes and initiates the expression of those genes.   
 
In studies utilizing homozygous Nrf2-deficient mouse model (Nrf2-/-), researchers 
have found that the induction of CAT [70], SOD [70], GSR [71] and GPx [72] are mediated 
by Nrf2 through the Nrf2-ARE pathway, yet are dependent on cells and organs used as 
material. Akino et al. (2018) in their research with human luteinized granulose cells from 
ovarian follicles have additionally demonstrated that depletion of endogenous Nrf2 resulted 
in a significant decrease in protein expression of CAT and SOD [73].  
Additionally, Nrf2 also plays a key role in regulation of phase II detoxifying enzymes 




(GST), NAD(P)H: quinone oxidoreductase (NQO1), and heme oxygenase (HO-1) [36, 69, 
76].  Lee et al. (2003) have also identified many of Nrf2-dependent genes in their research 
with mouse primary astrocytes using oligonucleotide microarray analysis. These genes 
enconde, among other things, growth factors, signaling proteins, and metabolic enzymes [77].  










Figure 2.4. Relation between ROS, oxidative stress, antioxidants and Nrf2 in stressed cells. 
 
2.3 White blood cells and PBMCs 
 
The white blood cells (WBCs), also called leucocytes, are one of three main 
components of the blood system besides red blood cells (RBCs)/erythrocytes and 
thrombocytes/platelets. 
The WBCs are divided into three different types: granulocytes, monocytes, and 
lymphocytes. Granulocytes comprise neutrophils, eosinophils, and basophils. They have, in 
addition to granular cytoplasm, segmented nuclei with varying shapes. Therefore, they are 
often referred to as polymorphonuclear leucocytes (PMNLs) [78-81]. Monocytes and 
lymphocytes, on the contrary, have neither cytoplasmic granules nor multi-lobed nuclei and 
thus are called peripheral blood mononuclear cells (PBMCs) [81-83]. The WBCs do not have 
hemoglobin, but they contain the same organelles, such as mitochondria, Golgi apparatus, 
nucleus, ER, and ribosomes as other eukaryote cells [79, 81]. Monocytes are the largest 
activation 
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peripheral blood cells whose diameter is 10-18 µm, while lymphocytes are the smallest ones 
measuring 10-14 µm in diameter [84].  
White blood cells are inflammatory cells [85] which defend the body against harmful, 
non-self or foreign agents and eliminate degraded components of self [80, 83]. These 
functions have been shown to be associated with the Keap1-Nrf2 pathway. Nrf2 in WBCs are 
activated by inflammatory related molecules such as prostaglandins and nitric oxide (NO). 
Since Nrf2 suppress accumulation of ROS generated by the NADPH oxidase complex in 
macrophages and neutrophils, their expression exerts anti-inflammatory effects, inhibits 
tumor metastasis and attenuates protection of tumor cells. Research on Nrf2-deficient mice 
also indicated that Nrf2 regulates phagocytosis [86].  
 
2.4 Principle of Western blot  
 
Western blot (WB) is a technique used to detect and identify specific proteins in a 
protein mixture [87]. The proteins are separated by gel electrophoresis and subsequently 
transferred from the gel to a membrane for detection using specific polyclonal or monoclonal 
antibodies. The specificity of the antibody-antigen (proteins, or part of them) interaction is 
therefore important.    
 
2.4.1 Protein separation by gel electrophoresis 
 
Gel electrophoresis is a method used for analytical separation of proteins in a mixture. 
The size of molecules of current interest determines the concentration of gel material and the 
size of pores in the gel [19, 88]. In this project, sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE), a variant of gel electrophoresis, was utilized. In SDS-PAGE, 
the loading buffer contains anionic detergent such as SDS (CH3-(CH2)10-CH2OSO3
-Na+) or 
LDS (CH3-(CH2)10-CH2OSO3
-Li+) and reducing agent; either dithiothreitol (DTT) or β-
mercaptoethanol (2-thioethanol). LDS has a better solubility than SDS at low pH and 
temperature [89]. The detergent denatures native proteins by disrupting nearly all 
noncovalent interactions found in them, while the reducing agent is added to reduce disulfide 
bridges that participate in proteins’ tertiary structure [19, 20, 88]. Since the LDS-denatured 
protein complexes have a strong negative charge which is proportional to the mass of the 




current is applied. The velocity of migration depends on size or mass of the proteins, 
electrical field strength, and concentration of gel material. If the last two factors are constant, 
the separation of the molecules is be related solely to their size. The smallest molecules will 
move faster due to molecular sieving effect in the gel [19, 88].  The polyacrylamide gel used 
in SDS-PAGE consists of two types of gel: a stacking gel that has high porosity to 
concentrate the proteins, resulting in sharp bands and a separating gel with a higher 
concentration of polyacrylamide, meaning lower porosity, thus separating the proteins based 
on their sizes [88].   
 
2.4.2 Protein detection  
 
Prior to protein detection in Western blot by chemiluminescence or fluorescence the 
following three steps are performed [19, 87, 88, 90, 91]: 
1) Blotting: The separated proteins migrate out of the gel onto a membrane when an electric 
current is applied at a 90 degrees angle to the gel. 
2) Blocking: The membrane is blocked to prevent non-specific binding between the detection 
antibody and the remaining protein binding sites of the membrane because the antibody, in 
essence, is also protein. There are many blocking agents that can be employed; for example, 
bovine serum albumin (BSA), skim milk powder, fetal calf serum, Tween 20, or gelatin.  
3) Antibody incubation: The membrane is incubated first in a primary antibody and then in a 
secondary antibody. The primary antibody has the function of detecting the protein of interest 
because of its specificity for the target protein or part of target protein. The secondary 
antibody, on the other hand, is specific to the first antibody and therefore binds directly to it. 
When this has happened, a sandwich structure is formed. The secondary antibody is 




The secondary antibody is conjugated with enzyme horseradish peroxidase (HRP). 
The membrane is incubated in substrate for HRP. The reaction between the substrate and 
HRP produces chemiluminescence which is detected by camera in an imaging system (figure 






 The secondary antibodies used are conjugated to fluorophores or fluorescent dyes 
such as cyanines (Cy2, Cy3 and Cy5) (figure 2.5B). A fluorophore is excited when it absorbs 
light from the light source at a specific excitation wavelength. The excitation leads to the 
subsequent emission of radiation or fluorescence in form of visible light at its specific 
emission wavelength when the fluorophore returns to the ground state. The fluorescent signal 
which visualizes the proteins of interest is then detected by a sensitive digital camera in the 
imager [88, 92]. The signal is proportional to the amount of the target protein. A benefit of 
fluorescent Western blot is the ability to examine multiple proteins simultaneously on a 
membrane, called multiplex detection, by utilizing primary antibodies from different host 
species (rabbit, mouse or rat) and secondary antibodies conjugated to fluorophores with 









Figure 2.5. Principle of chemiluminescent (A) and fluorescent detection (B) in Western blot.  
 
2.5 Principle of ELISA and ELISA-based TransAM Nrf2 kit 
 
ELISA is technique used to detect and quantify a protein colorimetrically. The 
technique relies on the formation of antigen-antibody complex followed by detection of its 
presence by addition of substrate of report enzyme [19, 20, 88].  
The ELISA-based TransAM Nrf2 kit (Active Motif, Carlsbad, CA) used in this 





The wells are precoated with immobilized oligonucleotide containing the ARE 
consensus binding site (5’-GTCACAGTGACTCAGCAGAATCTG-3’) which functions as 
capturer for Nrf2. Nrf2 in samples will bind to the capturer and become trapped. Nrf2 
operates henceforth as an antigen for a primary antibody added in the next step. 
Subsequently, an anti-species antibody, called secondary antibody, which is specifically 
against the primary antibody is used. The secondary antibody is already conjugated with the 
enzyme HRP. Thus, when an enzyme substrate is added in the final step, the ARE-bound 
Nrf2/primary antibody/secondary antibody complex produces color whose absorbance at a 
particular wavelength is measured in a spectrophotometer (figure 2.6). The intensity of the 
color product is used to assess the abundance of Nrf2 detected [19, 20, 88, 93].  
For analysis of positive control in the kit, competitive ELISA is employed. The coated 
capturer in the wells competes with either wild-type or mutated consensus oligonucleotide, 
for binding to Nrf2 in test samples. Since the competitive capturers are mobilized, the 
complex formed between it and Nrf2 is easily removed in washing steps. As a result, the 
signal from the target Nrf2 is decreased in detection, which indicates that a prevention of 

























Cell preparation tube (CPT) with sodium citrate, 8mL from BD Biosciences, New Jersey, 
USA.  
Microtainer® tube with no additive (red) from BD, New Jersey, USA.  
NP-40 (nonidet-P40, aqueous detergent solution 10% (w/v), catalog number: 28324, lot 
number: OD183328) from Thermo Fisher Scientific, Rockford, Illinois, USA. 
Phosphate-buffered saline (PBS) packs (0.1 M sodium phosphate, 0.15 M sodium chloride, 
pH 7.2 dissolved in a final volume of 500mL deionized water) from Thermo Fisher 
Scientific, Rockford, Illinois, USA. 
Trizma® base (hereafter referred to as Tris base) from Sigma-Aldrich, Steinheim, Germany 
Sodium chloride (NaCl) from VWR International AS, Leuven, Belgium 
Sodium deoxycholate from Sigma-Aldrich, Steinheim, Germany 




Bradford reagent (for detection of the total protein concentration with the range of 0.1-
1.4 mg/mL) from Sigma-Aldrich, Steinheim, Germany. 
Bovine serum albumin (BSA, heat shock fraction, protease free, fatty acid free, essentially 




Polystyrene microplate, clear, flat bottom (catalog number: 655101, lot number: E140716F 
and E100301J) from Greiner Bio-One, Frickenhausen, Germany.   
 
Western Blot 
SDS-PAGE/Gel electrophoresis  
Bolt™ 10% bis-tris plus gels (1.0 mm x 12 wells) (hereafter referred to as bolt gel) from Life 
Technologies, Invitrogen by Thermo Fisher Scientific, Carlsbad, California, USA. 
Bolt™ sample reducing agent (10 x) from Life Technologies, Invitrogen by Thermo Fisher 
Scientific, Carlsbad, California, USA.  
Bolt™ MOPS SDS running buffer (20x) from Life Technologies, Invitrogen by Thermo 
Fisher Scientific, Carlsbad, California, USA. 
Pageruler™ plus prestained protein ladder from Thermo Fisher Scientific, Rockford, Illinois, 
USA.   
Supersignal™ molecular weight protein ladder from Thermo Fisher Scientific, Rockford, 
Illinois, USA.   
Pierce™ lithium dodecyl sulfate (LDS) sample buffer non-reducing (4 x) from Thermo 
Fisher Scientific, Rockford, Illinois, USA.   
Dithiothreitol (DTT, BioUltra, for molecular biology, ≥99.5% (RT)) from Sigma-Aldrich, 
Steinheim, Germany.  
Protein detection 
1-step™ transfer buffer, Western blotting filter paper (7cm x 8.4cm, thickness: 0.83mm) 
from Thermo Fisher Scientific, Rockford, Illinois, USA. 
Polyvinylidene difluoride (PVDF) transfer membrane (0.45 µm, 26.5 cm x 3.75 m roll for 
western blotting applications) from Thermo Fisher Scientific, Rockford, Illinois, USA. 
Rabbit anti-HPRT monoclonal primary antibody (catalog number: ab133242, lot number: 




Mouse anti-GAPDH monoclonal primary antibody (catalog number: ab9484, lot number: 
GR174666-7) from Abcam, Cambridge, UK. 
Rabbit anti-Nrf2 (C-term) polyclonal primary antibody (catalog number: 10214) from 
Cayman Chemical, Michigan, USA. 
Rabbit anti-Nrf2 (N-term) polyclonal primary antibody (catalog number: 14114, batch: 
0480703-1) from Cayman Chemical, Michigan, USA. 
Mouse anti-Lamin B1 (L-5) monoclonal primary antibody (catalog number: 33-2000, lot 
number: QG215256) from Thermo Fisher Scientific, Rockford, Illinois, USA.   
Supersignal™ west femto maximum sensitivity substrate from Thermo Fisher Scientific, 
Rockford, Illinois, USA.   
Rabbit anti-Nrf2 polyclonal primary antibody (catalog number: 61599, lot number: 
25414001) from Active Motif, La Hulpe, Belgium.  
Goat anti-rabbit IgG conjugated to HRP polyclonal secondary antibody (catalog number: 
15015, lot number: 27117008) from Active Motif, La Hulpe, Belgium.  
Goat anti-mouse IgG, peroxidase conjugated, H+L polyclonal secondary antibody (catalog 
number: AP124P, lot number: 2966512) from Merck Millipore, Massachusetts, USA.  
Tween® 20 (Polysorbate), technical from VWR, Fontenay-sous-Bois, France. 
Ponceau S solution (BioReagent, suitable for electrophoresis, 0.1 % (w/v) in 5% acetic acid) 
from Sigma-Aldrich, Steinheim, Germany.  
Benzonase® nuclease (≥ 250 unites/µL, ≥ 90% (SDS-PAGE), recombinant, expressed in 
E.coli, buffered aqueous glycerol solution) from Sigma-Aldrich, Steinheim, Germany.  
Glycine (for electrophoresis, ≥ 99%) from Sigma-Aldrich, Steinheim, Germany.  
BSA (heat shock fraction, protease free, fatty acid free, essentially globulin free, pH 7, ≥ 
98%) from Sigma-Aldrich, Steinheim, Germany.  
Methanol, for analysis from Merck, Darmstadt, Germany 




Hydrochloric acid (HCl) fuming 37%, for analysis from Merck, Darmstadt, Germany 
AzureSpectra rb650/ms550 western kit, with fluorescent block from Azure Biosystems, 
Dublin, California, USA 





Bradford assay and ELISA 




XCell surelock™ mini-cell electrophoresis system for gel electrophoresis from Life 
Technologies, Invitrogen by Thermo Fisher Scientific, Carlsbad, California, USA. 
 Pierce power blotter system and Pierce power blot cassette for electrotransfer of separated 
proteins from gel onto activated PVDF membrane from Thermo Fisher Scientific, Rockford, 
Illinois, USA. 












PBMCs from blood samples were isolated using two different methods, one provided 
by the manufacturer of CPTs (method 1) and one developed at the laboratory of Stavanger 
University Hospital (method 2). The yield of isolated PBMCs of the two methods were 
compared to find out the method with highest yield. For the comparison, two parameters used 
were: 1) total number of isolated PBMCs and 2) total protein concentration in isolated 
PBMCs.   
Initially, Nrf2 was characterized in cell lysates of isolated PBMCs in Western blot 
using three different anti-Nrf2 antibodies. After the characterization, PBMCs were 
fractionated to obtain whole cell, cytosolic, and nuclear fractions. Western blot was used 
again to detect Nrf2 in the fractions and to determine their purity. The purity determination 
and Nrf2 detection were performed simultaneously. For the purity determination, antibodies 
against Lamin B1, which is the nuclear reference protein, HPRT and GAPDH, which are the 
cytosolic reference proteins, were employed. In addition to Western blot, the ELISA-based 
TransAM was used to detect and measure Nrf2 level in cytosolic and nuclear fraction (figure 
1.1, page 8). 
 
3.2.1 Sample preparation 
 
3.2.1.1 Isolation of PBMCs 
Blood from volunteers was collected in CPTs and subsequently centrifuged at 
1,600 x g for 30 minutes at room temperature (RT) (figure 3.1) in a swing-out bucket rotor.  
 
Method 1 
The method followed the protocol provided by BD Biosciences in product insert for 
CPT with sodium citrate.  
Immediately after centrifugation, the upper half of the plasma was discarded. The 
residual, including an undisturbed cell layer, was transferred to a new 15 mL conical 
centrifuge tube with cap. The final volume in the tube was brought up to 15 mL by adding 
ice-cold PBS. The tube was inverted 5 times and subsequently centrifuged for 15 minutes at 




was resuspended in the remaining PBS. The cell pellet was mixed with 10 mL ice-cold PBS 
followed by a centrifugation at 300 x g for 10 minutes at RT. After centrifugation, as much 
supernatant as possible was removed without disturbing the cell pellet, and the cell pellet was 
resuspended in the remainder of PBS for further procedure.  
 
Method 2 
Immediately after centrifugation, the entire content of the tube above the gel was 
poured into a new 15 mL conical centrifuge tube with cap in order to homogenize  
mononuclear cells and plasma. The tube was subsequently centrifuged for 10 minutes at 4 °C 
at 200 x g (program 1). After centrifugation, as much supernatant as possible was discarded 
without disturbing the cell pellet. The cell pellet was then washed 2 times, each in 10 mL ice-
cold PBS followed by centrifugation using program 1 and the removal of supernatant. 
Thereafter, the cells were dissolved in the remaining PBS. They were then transferred into a 
new Eppendorf tube and placed on ice. Cells which were not used on the same day were 












Figure 3.1. Layer of elements formed in CPTs before and after centrifugation.  
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3.2.1.2 Cell lysis 
 
Prior to the preparation of the cell lysate, the volume of isolated cells was determined.   
The isolated cells were then dissolved completely in RIPA buffer in a ratio of 1:1 (See 
Appendix 2: Solutions for detailed recipe). The cells-RIPA mixture was incubated on ice for 
40 minutes followed by centrifugation at 13,000 x g for 15 minutes at 4 °C. The supernatant 
was transferred into a new tube for further analysis. The cell pellet was discarded.  
 
3.2.1.3 Cell fractionation   
 
The procedure was adopted from the protocol “Rapid isolation of nuclei from cells in 
vitro” where a rapid, efficient and practical (REAP) method was described by Nabbi and 
coworkers (2015) [94]. Some modifications have, however, been made to adapt fractionation 
for PBMCs.  
The cell pellets obtained after isolation were resuspended in 300 µL ice-cold PBS for 
washing. The mixture was centrifuged at 9,391 x g for 13 seconds at RT. After 
centrifugation, the supernatant was removed, and the cell pellet was resuspended in 300 µL 
ice-cold 0.1% NP-40 in PBS (See Appendix 2: Solutions for detailed recipe) and triturated 
several times using a p1000 micropipette. 100 µL of the cell suspension was transferred into 
a new Eppendorf tube and designated as “whole cell” fraction. The residual cell suspension 
was centrifuged at 9,391 x g for 13 seconds at RT. The obtained supernatant was thereafter 
transferred into a new Eppendorf tube and named as “cytosolic” fraction. The remaining 
pellet was resuspended for the second time in 300 µL ice-cold 0.1% NP-40 in PBS. After 
being centrifuged as mentioned above, the supernatant was discarded, and the pellet was 

































Figure 3.2. Four steps in the protocol for REAP cell fractionation, which gives three final 
products: whole cell, cytosolic, and nuclear fraction.  
Nuclear fraction 
0.1% NP-40 in PBS 
  Centrifugation 
Supernatant 
Nuclei in pellet 
0.1% NP-40 in PBS 



















3.2.2 Evaluation of isolation of PBMCs 
 
PBMCs were isolated from six vials from one person, three by method 1, and three by 
method 2. One portion of each isolated cell sample was used in the counting of the total 
number of isolated PBMCs, and the rest was used in protein concentration determination.  
For cell counting, the isolated cell sample was diluted at 1:100 in PBS in microtainer 
tube with no additive. Flow cytometry was employed. The method measured intensity of 
fluorescence and scattered light of each component in the sample when it passed through a 
laser beam [83, 88].  
For protein concentration determination, PBMCs were first lysed in RIPA buffer, then 
the protein concentration was measured with a Bradford assay. 
 
Bradford assay for protein quantitation  
Establishment of calibration standard curve 
One gram dry BSA was dissolved in 10 mL ultrapure water to make a stock solution 
of 100 g/L BSA.  From the 100 g/L (= 100 mg/mL) BSA solution, a concentration series 
from 0.15 mg/mL to 1.3 mg/mL was prepared (table 3.3).   
Table 3.3: BSA dilution series for Bradford calibration standard curve  
Standard BSA concentration 
(mg/mL) 




1 (Blank) 0 0 5000 
2 0.15 7.5 4992.5 
3 0.3 15 4985 
4 0.6 30 4970 
5 0,9 45 4955 
6 1.3 65 4935 
 
 
96 well plate assay 
The Bradford reagent was gently mixed and equilibrated to RT before use. The 
protein concentration was measured according to the manufacturer’s protocol. Samples were 
diluted in PBS prior to the measurement. In different wells, 5 µL of blank, 5 µL of each 




reagent was added into each well. After 25 minutes mixing on a microplate shaker at RT, 
absorbance at 595 nm was measured in Synergy H1 microplate reader.   
 
3.2.3 Western blot 
 
3.2.3.1 Characterization of Nrf2 in lysed PBMCs  
 
Sample preparation 
Ten µg of total protein was loaded per well in SDS-PAGE. The volume of each lysate 
used was determined according to formula 1: 
Volume (µL) =  
10 µg
Protein concentration (µg µL⁄ )
  
    (Formula 1) 
The loading buffer containing LDS (4x) and DTT (10x) were added to each loading 
lysate. The sample was then heated for 10 minutes at 70 °C and subsequently spun down 
briefly for 2-3 seconds before loading on a bolt gel. 
SDS-PAGE 
500mL of Bolt™ MOPS SDS running buffer (20x) was prepared by adding 25 mL of 
the running buffer in 475 mL ultrapure water. The bolt gel was run for 55 minutes at 160 V 
and 1 hour at 150 V. 
Blotting 
PVDF membrane was activated in methanol for about 1 minute and washed with 
ultrapure water 3 times, each time for 15 seconds. Afterwards, the membrane and four sheets 
of filter paper were equilibrated in transfer buffer for 10 minutes with gentle agitation. 
Instructions from Thermo Fisher Scientific for gel-to-protein transfer of proteins in the Pierce 
power blotter system was followed. The transfer of proteins to the membrane was then 
verified using Ponceau S staining [95].  
 
Blocking  
Before blocking, the membrane was washed thoroughly in 1 x tris-buffered saline 
(TBS) several times to get rid of the color from Ponceau S staining. The membrane was 




the membrane was washed 3 times for 5 minutes per wash with 1x tris-buffer saline with 
0.1% Tween® 20 (TBST). Preparation of the blocking buffer, TBS and TBST are described 
in detail in Appendix 2: Solutions.   
  
Antibody incubation  
After blocking and washing, the membrane was incubated in anti-Nrf2 primary 
antibody, diluted at 1:1,000 in milk (3% weight per volume (w/v)) solution, for 2 hours at RT 
with gentle agitation (recipe for milk (3% (w/v)) solution is provided in Appendix 2: 
Solutions). The membrane was washed 3 times for 5 minutes per wash with 1x TBST and 
subsequently incubated in anti-rabbit IgG HRP-conjugated secondary antibody diluted at 
1:30,000 in milk (3% (w/v)) solution for 1 hour at RT with gentle shaking. After incubation, 
the membrane was washed 3 x 5 minutes per wash with 1x TBST before protein detection.  
 
Chemiluminescent protein detection 
Following the washes in TBST, the membrane was incubated for 5 minutes in 
detection solution which was the substrate for the enzyme HRP according to the 
manufacturer’s instructions. Excess substrate was drained off after the incubation. The 
membrane was then covered by two transparent and clean plastic sheets. Any trapped air 
bubbles were removed. The membrane was exposed in the Azure c400 imaging system.  
 
Secondary antibody control 
To determine non-specific signals derived from secondary antibody, a lysate was 
subjected to Western blot where it was incubated with only anti-rabbit IgG HRP-conjugated 
secondary antibody. The incubation with primary antibody was omitted. 
 
3.2.3.2 Nrf2 detection in cellular fractions and purity determination 
 
Chemiluminescent detection 
All obtained nuclear fraction was used. Amount of whole cell and cytosolic fraction 
used was 65 µL. To reduce viscosity in the nuclear fraction caused by release of 
chromosomal DNA, 1 µL benzonase nuclease was added, followed by an incubation at 37 °C 




The Western blot protocol employed was described above. Loading buffer was added 
to each loading fraction. The bolt gel was run for 63 minutes at 140 V.  
To control the purity of fractions, HPRT, GAPDH and Lamin B1 were detected in 
addition to Nrf2. Since anti-Nrf2 antibody and anti-HPRT antibody were produced in rabbits, 
while anti-Lamin B1 antibody and anti-GAPDH antibody were produced in mice, each 
membrane was cut horizontally into two parts prior to the detection to prevent cross-
reactivity. Antibody dilutions are presented in table 3.4. 
GAPDH and Lamin B1 in the same fractions were detected after the previously used 
primary and secondary antibodies were removed from the current membrane by stripping. 
The membrane was incubated twice in glycine-HCl stripping solution at RT for 10 minutes, 
followed by washing with PBS (2 x 10 minutes) and with TBST (2 x 5 minutes) with gentle 
shaking. After the removal av TBST, the membrane was re-blocked and re-probed with new 
primary antibodies. Preparation of the stripping solution is described in detail in Appendix 2: 
Solutions.  
The same detection solution as mentioned above was used. 
Table 3.4. Summary of antibody dilutions used in chemiluminescent detection 
Primary 
antibody 
Dilution Diluent Secondary 
antibody 











(w/v)) solution Rabbit  
anti-HPRT 
antibody 



























All nuclear fraction (approximately 10 µL), 65 µL of whole cell and cytosolic fraction 
was used in gel electrophoresis.  The bolt gel was run for 63 minutes at 140 V.  
Detection of Nrf2, HPRT, GADPH and Lamin B1 was done simultaneously by using 
AzureSpectra rb650/ms550 western kit, with fluorescent block. The protocol supplied in the 
kit was followed. After SDS-PAGE, the proteins were blotted to a low fluorescence PVDF 
membrane. Later, the membrane was blocked for 1 hour at RT in 1x Azure fluorescent blot 
blocking buffer followed by 1-hour incubation at RT in primary antibodies. Antibody 
dilutions were the same as described above, but the solution used was 1x Azure fluorescent 
blot blocking buffer instead of milk (3% (w/v)) solution or BSA (3% (w/v)) solution. After 
the incubation, the membrane was washed with 1x Azure fluorescent blot washing solution 
(2 x 5 seconds and 3 x 5 minutes). Preparation of 1x Azure fluorescent blot washing solution 
is described in detail in Appendix 2: Solutions. Afterwards, the membrane was incubated for 
1 hour at RT in secondary antibodies (1:2,500). The membrane was washed five times as 
described above followed by one wash of 5 minutes in TBS. After washing, the bands on the 
membrane were visualized. The settings for imaging Cy3 and Cy5 were used, producing a 
green and a red fluorescent color, respectively.   
 
3.2.4 ELISA-based TransAM  
 
Three experiments with different objectives were performed. The first experiment’s 
purpose was to verify the quality of the positive control provided in the kit before it was used 
in detection. The second was performed to elucidate correlation between amount of nuclear 
fraction and Nrf2 level, while the third was performed to analyze and compare cytoplasmic 
levels of Nrf2 with levels in the nucleus.  
Sample preparation 
Samples and buffers were prepared according to the manufacturer’s protocol. For 
cellular fraction, cell fractionation protocol (section 3.2.1.3) was used. The nuclear fractions 
were resuspended in complete lysis buffer, and agitated gently on ice for 30 minutes on an 
orbital shaker, and centrifuged at 14,000 x g for 10 minutes at 4 °C. The supernatant 





Detection of Nrf2 level 
Nrf2 level in cell fractions were detected using the ELISA-based TransAM according 
to the manufacturer’s protocols. The competitive assay was performed only with the positive 
control provided in the kit because of the shortage of nuclear fraction material. 
For blocking, complete binding buffer was added to each well. In wells with 
competitive assay, complete binding buffer containing either wild-type oligonucleotide or 
mutated oligonucleotide was added instead. The plate was sealed and incubated with mild 
agitation for 1 hour at RT. After incubation, each well was washed 3 times with 1x washing 
buffer. Then, anti-Nrf2 antibody (1:1,000) was added to each well. The plate was sealed and 
incubated for 1 hour at RT without agitation. After that, each well was washed 3 times. 
Subsequently, secondary antibody (1:1,000) was added followed by sealing and incubation 
without agitation as described above. After the incubation, each well was washed 4 times. To 
visualize the ARE-bound Nrf2/anti-Nrf2/secondary antibody complex, developing solution 
was added. The plate was incubated for 15 to 30 minutes at RT without agitation and 
protected from direct light. The development solution reacted with HRP, producing blue 
color. After the incubation, stop solution was added to cease the blue color development. The 
color turned from blue to yellow in the wells. Absorbance was measured at a wavelength of 
450 nm (Ab450) and at a reference wavelength of 655 nm (Ab655) in the Synergy H1 
microplate reader.  
To determine the Nrf2 level, optical density at 450 nm (OD 450 nm) or corrected 
absorbance values at 450 nm (corrected Ab450) were calculated by subtracting the Ab655 
values from the Ab450 values. The OD 450 nm values expressed the Nrf2 level in the fraction 
samples. 
 
3.2.5 Statistical analysis 
  
Average (A), standard deviation (SD) and coefficient of variation (CV%) were 
calculated to compare the two methods utilized in isolation of PBMCs in blood samples.  
In ELISA-based TransAM, Nrf2 levels, expressed as OD 450 nm values, in replicates of 
blank and of test samples were measured. Then, the average of OD 450 nm values of blank 
(A blank), the average of OD 450 nm values of test samples (A), standard deviation of OD 450 nm 
values of blank (SD blank) and standard deviation of OD 450 nm values of test samples (SD) 




  Limit of blank (LOB) is the lowest concentration of analyte which exceeds zero. Limit 
of detection (LOD) is the lowermost concentration of analyte which exceeds LOB. The LOD 
of Nrf2 level was determined according to formula 2 and 3, where SD sample was the SD of 
sample with lowest Nrf2 level:  
LOD = LOB + 1.65 x (SD sample)   (Formula 2) [96] 
LOB = A blank + 1.65 x (SD blank)   (Formula 3) [96] 
The results were assumed to approach normal distribution when the sample size 
increased. Student t-test was performed to determine whether Nrf2 levels in different samples 
measured in TransAM were significantly different from each other. A p value < 0.05 was 





4. Results  
 
Samples and their labelling used in the experiments are presented in table 1 and table 
2 in Appendix 1: Samples and their labelling.  
 
4.1 Evaluation of isolation of PBMCs 
Isolated cell samples from the same person, isolated with the two methods, varied 
from each other in PBMC count values and total protein concentration. Variation in PBMC 
count values were much larger than variation in total protein concentrations (table 4.1).   
Table 4.1. PBMC count values (x 109/L) and total protein concentrations (mg/mL) in isolated cell 
samples. The number of blood samples from one person used in each method was three (n=3). 
A1, SD1 and CV1: average, standard deviation and coefficient of variation, respectively, of 
PBMC count values. A2, SD2 and CV2: average, standard deviation and coefficient of 
variation, respectively, of total protein concentrations.  
A. Method 1 
Sample n 











P1 3 94.1 55.2 144.4 97.9 44.7 45.7 2.6 2.2 2.4 2.4 0.2 7.6 
P2 3 216.3 226.5 197.8 213.5 14.5 6.8 4.2 4.4 3.6 4.1 0.4 10.0 
P3 3 250.2 636.0 377.8 421.3 196.5 46.6 7.8 3.9 6.8 6.2 2.1 33.3 
 
B. Method 2 
Sample n 











P1 3 23.4 71.5 61.0 52.0 25.3 48.7 1.1 1.1 0.9 1.0 0.1 12.5 
P2 3 140.0 120.0 70.5 110.2 35.8 32.5 1.0 1.0 0.9 1.0 0.1 9.3 
P3 3 223.9 100.1 124.7 149.6 65.5 43.8 0.9 0.8 1.2 0.9 0.2 21.9 
 
The results showed that method 1 gave a higher yield of isolated cells than method 2. 
Protein concentration in cell samples isolated by method 1 was also higher than in cell 






























































Figure 4.1. Six blood samples, each from three individuals, were isolated by method 1 (n=3) 
and method 2 (n=3), denoted by red and blue indicators, respectively. Error bars display the 
standard deviation values.    
(A) Average of PBMC count values (x 109/L ± SD1, n=3)  

















































4.2 Western blot 
 
According to the manufacturers, anti-Nrf2 (C-term) from Cayman detect 
polyubiquitinated Nrf2 (pNrf2) at 90 kilodalton (kDa), anti-Nrf2 (N-term) from Cayman 
detects pNrf2 at 90 kDa and native Nrf2 (nNrf2) at 67 kDa, and anti-Nrf2 from Active Motif 
detect pNrf2 at 96 kDa.  
 
4.2.1 Characterization of Nrf2 in lysed PBMCs 
 
The MWs of detected bands in each lane in the triplicates or the quadruplicates were 
estimated in ImageJ [97]. The MWs of the detected bands in each lysate are mean values of 
MWs of each replicate.  
Anti-Nrf2 (C-term) detected pNrf2 in the all three lysates, giving prominent protein 
bands whose MWs ranging from approximately 94 to 96 kDa. Nrf2 bands were marked in 
bold font (figure 4.2).   
            
  
 
    
                            




   
 Figure 4.2. Representative images of different blots after Western blot analysis of the three 
lysate samples: L1 (A), L2 (B) and L3 (C) using the anti-Nrf2 (C-term) show one distinct 
band of the detected polyubiquitinated Nrf2 (pNrf2). Arrows indicate the positions at which 
the detected bands migrated. S: supersignal molecular weight protein ladder.  
61 kDa  62 kDa 
          L1      S        L1    
pNrf2- 94 kDa 
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Anti-Nrf2 (N-term) antibody detected both pNrf2 and nNrf2 in the three lysates, 
marked in bold font (figure 4.3). Bands of pNrf2 migrated at apparent MW of 94 kDa in 
lysate 1 and 95 kDa in lysate 2 and 3, while nNrf2 bands migrated at MW of 71 kDa in lysate 
1 and 3 and 72 kDa in lysate 2. 
Using anti-Nrf2 antibody from Active Motif (AM), multiple bands with different 
MWs emerged. Many of them were faint. One band in lysate 2 (L2) at about 94 kDa might be 











Figure 4.3. Anti-Nrf2 (N-term) detected polyubiquitinated Nrf2 (pNrf2) and native (nNrf2) in 
all three lysates: L1 (A), L2 (B) and L3 (C). Arrows indicate the positions at which the 





Figure 4.4. Representative image of Western blots after detection of polyubiquitinated Nrf2 
(pNrf2) in the three lysate samples (L1, L2 and L3) using the anti-Nrf2 antibody from AM. 
Arrow indicates the location of Nrf2 band. S: supersignal molecular weight protein ladder.           
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Secondary antibody control 
Without primary antibody, the secondary antibody detected bands at 53 kDa, 87 kDa 





Figure 4.5. In the absence of the primary antibody, the secondary antibody detected 
nonspecific bands at 53 kDa, 87 kDa and 120 kDa on the blot. L: Lysate. S: supersignal 
molecular weight protein ladder. 
 
4.2.2 Nrf2 detection in cellular fractions and purity determination 
 
The predicted molecular weights of HPRT, GAPDH and Lamin B1, supplied by the 
manufactures, are 25 kDa, 36 kDa and 68 kDa, respectively.  
The shown MW of detected protein in one sample was the mean value of three 
different MWs of the same protein detected in each fraction from this sample. To quantify 
obtained band, the band intensity was determined. Band intensity was proportional to the 
amount of the protein detected. The brighter the band, the higher the band intensity value. 
Both band intensities and MWs were determined using ImageJ [97].  
 
Chemiluminescent detection 
Anti-Nrf2 (N-term) antibody detected both pNrf2 and nNrf2 in the whole cell, 
cytosolic and nuclear fractions, but pNrf2 was the dominant form in all fractions compared 
with nNrf2. No nNrf2 was detected in three of the nuclear samples (N4, N5 and N6). In the 
cytosolic fractions, levels of pNrf2 and nNrf2 were much higher than those of pNrf2 and 
nNrf2 in the nuclear fractions (table 4.2). Reference proteins HPRT, GAPDH and Lamin B1 
were detected in all fractions, but the amounts were varying from fractions to fractions 
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Figure 4.6. Representative images of Western blots for polyubiquitinated Nrf2 (pNrf2), 
native Nrf2 (nNrf2), HPRT, Lamin B1 and GAPDH detected in the fractions from F4, F5, F6 
and F7. Arrows indicate the positions at which the detected bands migrated. S: supersignal 
molecular weight protein ladder. W: whole cell fraction. C: cytosolic fraction. N: nuclear 
fraction. 
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GAPDH and HPRT were strongly detected in whole cell and cytosolic fractions. 
Small amounts of HPRT and GAPDH were also present in nuclear fractions. The amount of 
Lamin B1, on the other hand, was high in the nuclear fractions and low in the whole cell and 
cytosolic fractions. Whole cell and cytosolic fractions contained almost equal amounts of 
pNrf2 (figure 4.7).  
Figure 4.7. Relative quantifying of the proteins which were detected in the different cellular 
fractions. W: whole cell fraction. C: cytosolic fraction. N: nuclear fraction. 
 
Table 4.2. Ratios between cytosolic pNrf2 level and nuclear pNrf2 level and between 









(CnNrf2/NnNrf2) pNrf2  nNrf2  
C4 15080 3967 24.5 
 
- 
 N4 616 0 
C5 14159 2300 32.3 
 
- 
 N5 439 0 
C6 15449 3280 13.1 
 
- 
 N6 1178 0 


































Fluorescent detection  
Lamin B1 was detected only in the nuclear fractions, whereas GAPDH and HPRT 
were strongly detected in all whole cell and cytosolic fractions. The levels of cytosolic pNrf2 
and nuclear pNrf2 were higher than the levels of nuclear pNrf2 and nNrf2 in all fractions 
except fractions C10 and N10. Fraction C10 contained less nNrf2 than fraction N10. In 
addition, no pNrf2 was detected in fraction N10. Beyond that, both pNrf2 and nNrf2 were 
detected in the other nuclear fractions and all whole cell and cytosolic fractions (table 4.3). 
Notably, a faint band of GAPDH was observed in all nuclear fractions, whereas a faint band 
of HPRT was observed in nuclear fraction N10 (figure 4.8).   
 
Table 4.3. Levels of pNrf2 and nNrf2 in the cellular fractions expressed as band intensities. 
Ratios between levels of cytosolic pNrf2 and nuclear pNrf2 and between levels of cytosolic 
nNrf2 and nuclear nNrf2 are also presented. W: whole cell fraction. C: cytosolic fraction. N: 
nuclear fraction 
Fractions  Band intensities pNrf2 ratio (C/N)  nNrf2 ratio (C/N)  
pNrf2 nNrf2 
W8 8912 2024   
C8 8081 1685 
90.9 1.5 
N8 89 1120 
W9 11808 1068   
C9 14292 1723 
28.4 1.2 
N9 504 1445 
W10 14225 2702   
C10 13382 2427 
- 0.6 
N10 0 4258 
W11 15739 3483   
C11 15482 4421 
9.2 1.2 




















      










Figure 4.8. Singel-channel scanned images of blots from the multiplexed fluorescent 
detection of Nrf2, HPRT, Lamin B1 and GAPDH in the cellular fractions. Nrf2 and HPRT, 
labelled with Cy5 conjugated to goat anti-rabbit, were detected in the red channel, while 
Lamin B1 and GAPDH, labelled with Cy3 conjugated to goat anti-mouse, were detected in  
the green channel accordingly. Arrows indicate the positions of signals from the detected 
proteins. S: supersignal molecular weight protein ladder. W: whole cell fraction. C: cytosolic 
fraction. N: nuclear fraction. A1 and A2 is the same membrane, and so is B1 and B2. 
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4.3 ELISA-based TransAM 
 
Verification of ELISA kit  
The results from the experiment are reported in table 4.4. LOD (OD 450 nm) in the 
experiment is 0.01155 ≈ 0.012 (formula 2).  
Table 4.4. Nrf2 level in different controls expressed as optical density at 450 nm (OD 450 nm)  
Sample n 
OD 450 nm 
A SD CV (%) 
Blank 8 0.000 0.004 - 
Pa 8 0.081 0.011 14.166 
PWb 4 0.058 0.003 4.473 
PMc 4 0.093 0.003 3.649 
A: average. SD: standard deviation. CV: coefficient of variation.  
a: Positive control with no competitive element. 
b: Positive control with competitive wild-type consensus oligonucleotide. 
c: Positive control with non-competitive mutated consensus oligonucleotide.  
 
 
The average Nr2 level in wells with only positive control (P) and wells with positive 
control and non-competitive mutated oligonucleotide (PM) was significantly higher than the 
average Nrf2 level in wells with positive control and wild-type competitor (PW) (p < 0.05). 
There was no significant difference (p > 0.05) between the wells with only P and the wells 
with PM although the former had a lower average Nrf2 level than the latter, 0.081 and 0.093, 









Figure 4.9. Average of Nrf2 levels (± SD) in wells with positive control (P), in wells with 
positive control and the competitive wild-type oligonucleotide (PW) and in wells with 
positive control and the non-competitive mutated oligonucleotide (PM). OD 450 nm: optical 
density at 450 nm.  
 
Nrf2 level in nuclear fractions 
The average Nrf2 level in N13a was higher than the average Nrf2 level in N13b, 
which was as expected because N13a had a higher amount of nuclear fraction than N13b. By 
contrast, the average Nrf2 level in the nuclear fraction N12a was lower than the average Nrf2 
level in the nuclear fraction N12b although the former sample contained twofold more 
nuclear material than the latter (table 4.5). LOD (OD 450 nm) in the experiment is 
0.0198 ≈ 0.020 (formula 2). In six of eight nuclear functions, the average Nrf2 levels fell 
below the LOD. In sample N13a and N14a, the error bars reached 0, while in sample N14b, 
N15a and N15b, the error bars reached the negative side of the y-axis. This indicated that 





























P                              PW                             PM
n = 8                          n = 4                          n = 4
CV (%) = 14.166 CV (%) = 4.473            CV (%) = 3.649
0.012 LOD
p < 0.05








































Table 4.5. Average Nrf2 level expressed as optical density at 450 nm (OD 450 nm) in controls 
and in samples with different amount of nuclear fraction.  
Sample n OD 450 nm 
A SD CV (%) 
Blank 4 0.000 0.004 - 
Pa 4 0.058 0.005 8.963 
PWb 4 0.050 0.019 38.046 
PMc 4 0.067 0.011 15.847 
N12a 5 0.012 0.003 27.812 
N12b 5 0.024 0.005 20.581 
N13a 5 0.028 0.004 13.314 
N13b 5 0.008 0.008 106.665 
N14a 5 0.006 0.006 101.389 
N14b 5 0.004 0.009 192.891 
N15a 5 0.000 0.008 38764.352 
N15b 5 0.003 0.005 161.018 
A: average. SD: standard deviation. CV: coefficient of variation.  
a: Positive control with no competitive element. 
b: Positive control with competitive wild-type consensus oligonucleotide. 








Figure 4.10. Average Nrf2 level (± SD) in controls and in the nuclear fractions. 
OD 450 nm: optical density at 450 nm. P: positive control and no competitive element. PW: 
positive control and competitive wild-type consensus oligonucleotide. PM: positive control 
and non-competitive mutated consensus oligonucleotide.  
 
LOD 
                     P       PW       PM       N12a    N12b    N13a    N13b    N14a    N14b   N15a    N15b 




Nrf2 in cytosolic and nuclear fractions 
LOD (OD 450 nm) in the experiment is 0.01818 ≈ 0.018 (formula 2). In three of four 
nuclear functions, the average Nrf2 levels fell below the LOD. On the contrary, the average 
Nrf2 levels in all four cytosolic fractions exceeded the LOD (table 4.6 and figure 4.11).  
Moreover, the cytosolic fractions contained significantly higher average Nrf2 level than the 
nuclear fractions (p < 0.05) (table 4.6 and figure 4.12).  
Table 4.6.  
A. Average Nrf2 level expressed as optical density at 450 nm (OD 450 nm) in controls, cytosolic 
fractions and nuclear fractions.  
B. Calculated average of Nrf2 levels of all four cytosolic and nuclear fractions  





A: Average. SD: standard deviation. CV: coefficient of variation. 
a: Positive control with no competitive element. 
b: Positive control with competitive wild-type consensus oligonucleotide. 






OD 450 nm 
A SD CV (%) 
Blank 4 0 0.007 - 
Pa 4 0.095 0.012 12.635 
PWb 4 0.038 0.008 21.133 
PMc 4 0.073 0.011 14.906 
C16 3 0.047 0.005 10.427 
N16 3 0.002 0.004 203.191 
C17 3 0.039 0.003 7.614 
N17 3 0.021 0.002 9.323 
C18 3 0.035 0.002 6.635 
N18 3 0.010 0.007 63.705 
C19 3 0.053 0.011 20.408 
N19 3 0.017 0.008 47.234 
Sample n 





16 3 0.047 0.002 
17 3 0.039 0.021 
18 3 0.035 0.010 
19 3 0.053 0.017 
A Nrf2 level in all fractions 0.044 0.013 






Figure 4.11. Average Nrf2 level (± SD) in controls, cytosolic and nuclear fractions from four 
healthy people. LOD=0.021. OD 450 nm: optical density at 450 nm. P: positive control and 
no competitive element. PW: positive control and competitive wild-type consensus 
oligonucleotide. PM: positive control and non-competitive mutated consensus 
oligonucleotide.   
Figure 4.12. Two-tailed Student’s t-test for paired values was performed for comparison of 
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5. Discussion  
 
5.1 Evaluation of isolation of PBMCs 
 
The numbers of PBMCs in samples isolated by method 2 were not as high as the 
numbers of PBMCs in samples isolated by method 1. As a result, the protein concentrations 
in those samples were also low compared to the protein concentrations in the samples with 
PBMCs isolated by the first method. The main reasons for the differences might be the short 
centrifugation time, which was 10 minutes, and the low centrifugation speed, which was 
200 x g, applied in method 2. Therefore, even though method 1 showed a greater dispersion 
of cell count and total protein values, i.e. higher CV, than the other did, the results proposed 
that method 1 was better than method 2 in isolating PBMCs in blood samples.     
When analyzing blood samples taken from the same person, it is expected that the 
values of cell counting performed on these samples will not be significantly different. The 
results, on the other hand, demonstrated a significant difference in the numbers of PBMCs 
regardless of isolation method used. This was explained in the high SD and CV of both 
methods (table 4.1). The values of SD and CV indicated that both methods produced almost 
the same high dispersion of PBMC count numbers. It may be due to factors disturbing the 
measurement; the first could be aggregation of mononuclear cells because they were up-
concentrated in small volume, and the second could be cell loss during isolation.  
However, the determination of protein concentration in isolated cell samples gave 
converse results. The calculated values of SD and CV were small regardless of isolation 
method. When CV from protein concentration determination was compared with CV from 
cell counting, it was quite evident that protein concentration was a better implement to 
evaluate isolation yield.   
 
5.2. Western blot 
 
5.2.1 Nrf2 in lysates and cellular fractions 
 
Nrf2 was successfully detected in all lysates of PBMCs, indicating a considerable 
expression of the protein in PBMCs. Furthermore, the detection provided evidence to support 




plausible as it is well established that Keap1 constantly promotes Nrf2 ubiquitination and 
subsequent proteasomal degradation under homeostatic conditions. This regulatory pathway 
was also verified in WBCs in the study of Murakami et al. (2014) [98]. Although the MWs of 
detected Nrf2 were not identical to the MWs provided by the manufacturers, the differences 
between them were not significant. Moreover, Lau et al. have proved that Nrf2 migrates 
between approximately 95-110 kDa [99] despite its theoretical MW of about 68 kDa [100]. 
The discrepancy may be due to the abundance of acid residues in Nrf2 [99, 101] and the 
interaction between Nrf2 and actin [102]. Moreover, post-translational modification of Nrf2 
in vivo including acetylation, ubiquitination and phosphorylation [17, 45] could lead to 
slower mobility  [103-105]. As ubiquitin has a MW of about 9 kDa [106], polyubiquitinated 
Nrf2 could typically migrate a minimum 9 kDa slower than its unmodified forms, giving 
bands with higher MW then the theoretical MW. 
The characterization of Nrf2 in lysates showed that unstressed PBMCs contained a 
higher level of pNrf2 than nNrf2. The results of Nrf2 detection in cellular fractions of 
PBMCs and band intensities suggested the same conclusion (figure 4.6). They illustrated, at 
the same time, two points. First, whole cell and cytosolic fractions from the same person had 
almost equal level of Nrf2, and their overall Nrf2 level was higher than overall Nrf2 level in 
the nuclear fractions (figure 4.6 and 4.7). Second, in both cytosolic and nuclear fractions, the 
level of pNrf2 was higher than the level of nNrf2 (table 4.2). In addition, when anti-Nrf2 (N-
term) antibody was used, the migration pattern of Nrf2 in chemiluminescent detection in 
whole cell and cytosolic fractions was identical to that of Nrf2 in lysates. The bands were 
also detected at similar MWs as those in the lysates. By closer inspection of the images of the 
blots, the same pattern can also be observed in lanes loaded with nuclear fractions N6 and N7 
although the bands are very faint (figure 4.3 and 4.6). 
The results from fluorescent detection supported the findings in chemiluminescent 
detection. In whole cell and cytoplasm, the overall Nrf2 level in whole cell and cytosolic 
fractions was higher than the overall Nrf2 level in the nuclear fraction, and the amounts of 
cytosolic pNrf2 and nNrf2 were generally higher than the amounts of nuclear pNrf2 and 
nNrf2 (table 4.3 and figure 4.8).  
The Nrf2 activity in cells is tightly regulated by diverse pathways. Some of them have 
been identified, while some remain elusive [17]. For this reason, some observed bands on the 
membranes of the lysates and the fractions could be a form of Nrf2. The size of Nrf2 can be 
reduced by proteolysis as protease inhibitor was not used in RIPA buffer or by post-




and in vitro. Caspases are cysteine proteases which are central molecule in inflammasomes, 
and thus play an essential role in apoptosis, an active form of cell death.  In the study, Nrf2 
was cleaved and inactivated by caspase-3, producing two C-terminal fragments, 50 kDa and 
30 kDa [107]. Therefore, bands detected by anti-Nrf2 (C-term) at approximately 30 kDa or 
50 kDa might be caspase-cleaved forms of Nrf2. However, the interaction between caspase  
Nrf2 is not fully understood as it has been very limited investigated so far. Several groups 
have additionally demonstrated that Nrf2 is ubiquitinated and subsequently proteasomally 
degraded not only in cytoplasm but also in the nucleus [102, 108, 109].  Their finding 
substantiates the appearance of pNrf2 bands in the nuclear fractions and support the 
speculation that multiple bands detected in the nucleus might also be other forms of Nrf2. On 
the other hand, the equivocal bands may rather be non-specific. The secondary antibody 
control revealed that the anti-rabbit IgG HRP-conjugated secondary antibody could produce 
nonspecific bands (section 4.2.1).  
To confirm the equivocal bands were indeed Nrf2, cells should have been treated with 
canonical Nrf2 inducers such as tert-butylhydroquinone (tBHQ) or sulforaphane (SFN). 
Bands belonging to Nrf2 would increase in intensity in response to the treatment [99, 105]. 
Another way to identify specific bands would be to cut out bands from the gel and extract 
proteins from these bands. Specific proteins in the bands could then be identified using mass 
spectrometry [110].  
 
5.2.2 Purity determination 
 
The results from chemiluminescent detection were in concordance with the results 
from fluorescent detections. Nuclear lamina found inside the nucleus was present in the 
nuclear fractions as Lamin B1 which was strongly detected. In the whole cell and cytosolic 
fractions, HPRT and GAPDH were the dominant proteins (figure 4.6, 4.7 and figure 4.8). The 
essence of the fractions was confirmed. 
Results from Western blot indicated that fractionation of PBMCs in blood samples 
using REAP protocol was able to provide relatively pure fractions. Further test experiments 
are therefore required to modify the method to obtain more pure fractions. It is worth noting 
that although fractionation has widely been used in most researches where cells are involved, 
it is difficult to find reports in which fractions from WBCs are mentioned. The reason may be 




Compounding the limitation is the fact that number of isolated cells after isolation is low 
unless more than one blood sample is used. This issue raises questions about how many blood 
samples and how much PBMCs are needed to obtain sufficient fraction material.  
 
5.3 ELISA-based TransAM  
 
In attempt to increase detected Nrf2 levels, two nuclear samples were merged to one. 
However, the correlation between amount of nuclear fraction used and Nrf2 level failed to be 
established because the results were generally scattered. One reason may be that it was 
difficult to make exact replicates of nuclear fractions because of very limited numbers of 
isolated cells available; another may be that TransAM might be not sufficiently sensitive to 
detect Nrf2 level below LOD. As a result, some CVs were high, and some error bars reached 
the negative side (table 4.5 and figure 4.10). The first reason may be more rational as Nrf2 
expression level is supposed to be higher in granulocytes, monocytes and hematopoietic stem 
and progenitor cells (HSPCs) [98].  
In the third experiment, the cytosolic fractions exhibited significantly higher Nrf2 
levels than the nuclear fraction, which corresponded to the observations in the Western blot 
detection. The results of this experiment were consistent, suggesting that TransAM was more 
appropriate for Nrf2 measurement in cells with high Nrf2 abundance.  
 
 
5.4 Strengths and limitations of the study  
 
There were some shortcomings in the analyses. Protein concentration determination in 
the cellular fractions prior to gel electrophoresis, and purity determination before TransAM 
assay were not performed because of the shortage of nuclear material. In addition, the sample 
size for TransAM assay was small, and all samples were solely from healthy individuals. 
Moreover, the two methods themselves have both advantages and disadvantages. Western 
blot provided more dimensions for studying Nrf2 in PBMCs than TransAM assay. In Western 
blot, Nrf2 migration pattern and different forms of Nrf2 were uncovered. In addition, MW of 
Nrf2 and its level were determined. The disadvantage was that there is still confusion 
regarding the correct MW of Nrf2 detected and the specificity of anti-Nrf2 antibodies. 




and quantifying Nrf2. However, it might have difficulty in detecting and quantifying low 




PBMCs were revealed to contain both pNrf2 and nNrf2 with a distinct migration 
pattern in Western blot. The level of pNrf2 appeared to be higher than the level of nNrf2 in 
these cells. The results from both Western blot and TransAM assay showed, at the same time, 
that most Nrf2 was contained in the whole cell and cytosolic fraction as a very low level of 
nuclear Nrf2 was detected.    
In addition, this study demonstrated that both Western blot and TransAM were able to 
detect Nrf2 and measure Nrf2 level in cellular fractions of PBMCs. Whether Nrf2 can be 
used as a supplementary biomarker to evaluate oxidative stress-induced antioxidant status 
remains to be determined. Additional experiments are required to: 
- obtain more pure fractions of PBMCs that can be used in TransAM assay. Their purity can 
be verified, if desired, in Western blot.  
- evaluate if TransAM is suitable for measurement of Nrf2 level in fractions from PBMCs, 
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Appendix 1: Samples and their labelling  
 
An overview of lysates and their labelling is presented in table 1. Fractions and their 
labelling used in purity determination and detection of Nrf2 are presented table 2. 
 
Table 1. Overview of lysates used in evaluation of isolation of PBMCs and characterization 
of Nrf2.  
Person  Number of blood 
samples 
Labelling Test material Experiment 
P1 6 1-1 Lysate Method 1-Evaluation of 
isolation of PBMCs 1-2 
1-3 
1-4 Lysate Method 2-Evaluation of 
isolation of PBMCs 1-5 
1-6 
P2 6 2-1 Lysate Method 1-Evaluation of 
isolation of PBMCs 2-2 
2-3 
2-4 Lysate Method 2-Evaluation of 
isolation of PBMCs 2-5 
2-6 
P3 6 3-1 Lysate Method 1-Evaluation of 
isolation of PBMCs 3-2 
3-3 
3-4 Lysate Method 2-Evaluation of 
isolation of PBMCs 3-5 
3-6 
P4 3 L1 Lysate WB-Characterization of Nrf2 
P5 3 L2 Lysate WB-Characterization of Nrf2 









Table 2. List over fractions used in purity determination and detection of Nrf2. “a”: nuclear 
fraction obtained from fractionation of isolated cells from two of the three CPTs, while “b”: 
nuclear fraction obtained from fractionation of isolated cells from one of the three CPTs. 
Person  Number of 
blood samples 
Labelling Test material Experiment 
F4 2 W4 Whole cell fraction Chemiluminescent WB-Nrf2 
detection and purity 
determination 
C4 Cytosolic fraction 
N4 Nuclear fraction 
F5 2 W5 Whole cell fraction 
C5 Cytosolic fraction 
N5 Nuclear fraction 
F6 2 W6 Whole cell fraction 
C6 Cytosolic fraction 
N6 Nuclear fraction 
F7 2 N7 Whole cell fraction 
C7 Cytosolic fraction 
N7 Nuclear fraction 
F8 2 W8 Whole cell fraction Fluorescent WB-Nrf2 detection 
and purity determination C8 Cytosolic fraction 
N8 Nuclear fraction 
F9 2 W9 Whole cell fraction 
C9 Cytosolic fraction 
N9 Nuclear fraction 
F10 2 W10 Whole cell fraction 
C10 Cytosolic fraction 
N10 Nuclear fraction 
F11 2 W11 Whole cell fraction 
C11 Cytosolic fraction 
N11 Nuclear fraction 
F12 3 N12a Nuclear fraction ELISA-based TransAM Nrf2 
detection   N12b  Nuclear fraction 
F13 3  N13a  Nuclear fraction 
  N13b Nuclear fraction 
F14 3 N14a  Nuclear fraction 
  N14b  Nuclear fraction 
F15 3  N15a  Nuclear fraction 
  N15b  Nuclear fraction 
F16 2 C16 Cytosolic fraction 
  N16 Nuclear fraction 
F17 2 C17 Cytosolic fraction 
  N17 Nuclear fraction 
F18 2 C18 Cytosolic fraction 
  N18 Nuclear fraction 
F19 2 C19 Cytosolic fraction 




Appendix 2: Solutions 
 
10% sodium deoxycholate stock solution:  
For 10 mL: 
1 g sodium deoxycholate  
9 g (9 mL) ultrapure water  
 
1% sodium dodecyl sulphate (SDS) stock solution: 
For 10 mL: 
0,1 g SDS  
9,9 mL ultrapure water  
 
Radioimmunoprecipitation assay (RIPA) buffer: 
 For 500 mL: 
150 mM sodium chloride 4.38 g 
1.0% NP-40 10% (w/v)   5 mL 
0.5% sodium deoxycholate 2.5 mL of a 10 % stock solution 
0.1% SDS  0.5 mL of a 1% stock solution 
50 mM Tris, pH 8.0 3.03 g 
 
1. Dissolve 3.03 g Tris in 300 mL of ultrapure water  
2. Adjust pH to 8.0 with HCl fuming 37%  
3. Add the rest of the chemicals  
4. Add ultrapure water to bring the volume to 500 mL  
 
Phosphate-buffered saline (1x PBS)  
1 PBS pack (0.1 M sodium phosphate, 0.15 M sodium chloride, pH 7.2) 
Dissolve in a final volume of 500 mL of ultrapure water 
 
0.1% NP-40 in ice-cold PBS 1x 
For 100 mL: 
1 mL NP-40 10% (w/v)  




Tris-buffered saline 20x (20x TBS) 
For 500 mL: 
24 g Tris 
88 g NaCl  
1. Dissolve in 350 mL of ultrapure water  
2. Adjust pH to 7.6 with HCl fuming 37%  
3. Add ultrapure water to bring the volume to 500 mL  
 
Tris-buffered saline 1x (1x TBS) 
For 500 mL: 
25 mL TBS 20x  
475 mL of ultrapure water 
 
1x Tris-buffer saline with 0.1 % Tween® 20 (TBST) 
For 500 mL: 
25 mL TBS 20x  
475 mL of ultrapure water 
500 µL Tween® 20  
 
Blocking buffer (TBST with 5% (w/v) milk or BSA) 
For 15 mL: 
0.75 g milk or BSA 
Dissolve in a final volume of 15 mL TBST 
 
TBST with 3% (w/v) milk or BSA 
For 15 mL: 
0.45 g milk or BSA 








 For 1 L: 
200 mM glycine, pH 2.2 15 g glycine 
 0.1 % (w/v) SDS 1 g SDS 
 1 % (v/v) Tween® 20 10 mL Tween® 20  
  
1. Dissolve in 800 mL ultrapure water 
2. Adjust pH to 2.2 with HCl fuming 37%  
3. Add ultrapure water to bring the volume to 1 L  
 
1x Azure fluorescent blot washing solution 
For 300 mL: 
30 mL of 10x Azure fluorescent blot wash buffer (provided in the purchased kit) 






Appendix 3: Supersignal molecular weight protein ladder   
 
Figure 1 shows supersignal molecular weight protein ladder. The protein ladder was diluted 
at 1:50 in 4x LDS and ultrapure water before it was used in Western blot to estimate the 










Figure 1: Supersignal molecular weight protein ladder (Thermo Fisher Scientific) on a NuPAGE® 






Appendix 4: Bradford assay-Representative calibration standard 
curve 
 
The absorbance at 595 nm of the standards (table 3.3, page 27) was read in Synergy H1 
microplate reader. The linear regression line was plotted as the dashed line in figure 2.  
Figure 2. Representative BSA calibration standard curve used in Bradford assay for total protein 
determination. Orange points represents the average protein concentrations of each set of 
triplicate standards. Each error bar represents the average ± SD. Y: Absorbance at wavelength 





































Protein concentration (mg/mL) 
 
Y = 0.314 x X + 0.0017 
R2 = 0.994 
